Yahoo Suche Web Suche

  1. Improve Lab Quality & Productivity, Create Transparency and Gain Energy Savings. Act Now. Smart Lab Infrastructure Solutions from Siemens. Flexible Spaces for Critical Work.

Suchergebnisse

  1. Suchergebnisse:
  1. 27. Jan. 2023 · PHILADELPHIA, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and fully integrated gene therapy company dedicated to challenging the ...

  2. 25. Feb. 2019 · Roche has signed a definitive merger agreement to acquire all outstanding shares of US-based gene therapy company Spark Therapeutics for $114.50 per share, corresponding to a total of around $4.8bn on a fully diluted basis. Spark Therapeutics focuses on the discovery, development and delivery of gene therapies for genetic disorders.

  3. 17. Dez. 2019 · Spark will continue its operations in Philadelphia as an independent company within the Roche Group Basel, 17 December 2019 - Roche (SIX: RO,... December 17, 2019 08:55 ET | Source: F. Hoffmann-La ...

  4. Spark Therapeutics is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, gender identity, sexual orientation, age, religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law. Spark Therapeutics does not accept unsolicited resumes/candidate profiles from any source other than directly from ...

  5. 5. März 2019 · Spark’s meteoric rise from hospital-funded spinout to $4.8 billion deal. Roche vows to retain gene therapy leader’s culture. By. Chris Morrison. Roche’s acquisition of gene therapy developer ...

  6. 17. Dez. 2021 · PHILADELPHIA, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to ...

  7. 23. Feb. 2022 · The change comes a bit more than two years after Roche Group, a Swiss pharmaceutical giant, paid $4.8 billion for Spark, which was spun out of Children’s Hospital of Philadelphia in 2013. Ron Philip will become CEO of Philadelphia-based Spark Therapeutics on April 1, succeeding founding CEO Jeffery D. Marrazzo.